The first annual meeting of the European hepatitis B and C surveillance network takes place on 23-24 March 2011. Since 2009, ECDC has worked on preparing the enhanced surveillance of hepatitis B and C at EU/EEA level by establishing a network for hepatitis B and C surveillance and by carrying out a survey on prevention and surveillance activities in the Member States.
ECDC and EFSA have just launched the annual report on zoonoses and food-borne outbreaks in the European Union for 2009. The report shows that Salmonella cases in humans fell by 17% in 2009, marking a decrease for the fifth consecutive year
A new report, Tuberculosis surveillance in Europe 2009, a joint publication from ECDC and the WHO Regional Office for Europe to mark World Tuberculosis Day 2011, provides evidence for concern about the spread of multi-drug resistant tuberculosis (MDR TB) and the persistence of TB among children.
ECDC is hosting a meeting on childhood TB, in a joint effort to highlight the current situation and to move forward the agenda of childhood TB in the EU and worldwide.
Location:Piperska Muren Conference, Stockholm, Sweden
Organized by:ECDC together with the childhood TB subgroup of the Stop TB Partnership
First annual meeting of the network since it was transferred to ECDC in March 2010. Among the objectives of the meeting is to to present the epidemiological situation of diphtheria in Europe for 2009.
This winter celebration usually coincides with the winter flu season. As transmission frequently happens among children, it is important to prepare carefully for such events during the flu season to prevent the spread of influenza virus among the particip
Vaccination helps to prevent diseases and, above all, saves lives. This was the message at an expert meeting on childhood immunisation organised by the Hungarian Presidency. ECDC Director Marc Sprenger stressed the importance of successful vaccination programmes across Europe and future challenges.
Each year in February WHO convenes a meeting with advisers from the WHO Influenza Collaborating Centres and Essential Reference laboratories in order to achieve consensus and advise WHO on the optimal formulation of seasonal influenza vaccines for the next influenza season.